共 50 条
- [44] Response to “Do metastasis-free interval less or more than 24 months for recurrent metastatic breast cancer and primary surgery for de novo metastatic breast cancer matter for survival?” Breast Cancer Research and Treatment, 2017, 162 : 397 - 398
- [45] Clinical Characteristics and Survival Outcomes of Patients with De Novo Metastatic Breast Cancer BREAST CANCER-TARGETS AND THERAPY, 2022, 14 : 363 - 373
- [47] Characteristics and survival of de novo and recurrent metastatic breast cancer in New Zealand Breast Cancer, 2021, 28 : 387 - 397
- [48] Prognostic Factors and Their Impact on Survival in Patients with De Novo Metastatic Breast Cancer UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, 2025, 35 (01): : 41 - 50
- [50] Clinical Evidence for Locoregional Surgery of the Primary Tumor in Patients with De Novo Stage IV Breast Cancer Annals of Surgical Oncology, 2021, 28 : 5059 - 5070